Inspired by King’s word, the goal of optimal pharmacotherapy is optimizing patient outcomes in an appropriate and consistent fashion, integrating itself with other management strategies, when and as appropriate, but this goal cannot be achieved if such therapy is not implemented in a forceful and proactive fashion. Indeed, cardiovascular pharmacotherapy for ischemic heart disease due to coronary artery disease (CAD) represents a unique case study in this sense, given the complex interplay between societal and individual preventive strategies as well as clinical treatments aimed at secondary or tertiary prevention, which may apparently challenge immediate and thorough implementation.

Clinical conundrum. Three management strategies for three-vessel coronary artery disease? / Biondi-Zoccai, Giuseppe; Frati, Giacomo; Miraldi, Fabio; Chiariello, Giovanni A; Versaci, Francesco. - In: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. - ISSN 0160-2446. - 76:5(2020), pp. 489-491. [10.1097/FJC.0000000000000900]

Clinical conundrum. Three management strategies for three-vessel coronary artery disease?

Biondi-Zoccai, Giuseppe;Frati, Giacomo;Miraldi, Fabio;
2020

Abstract

Inspired by King’s word, the goal of optimal pharmacotherapy is optimizing patient outcomes in an appropriate and consistent fashion, integrating itself with other management strategies, when and as appropriate, but this goal cannot be achieved if such therapy is not implemented in a forceful and proactive fashion. Indeed, cardiovascular pharmacotherapy for ischemic heart disease due to coronary artery disease (CAD) represents a unique case study in this sense, given the complex interplay between societal and individual preventive strategies as well as clinical treatments aimed at secondary or tertiary prevention, which may apparently challenge immediate and thorough implementation.
2020
01 Pubblicazione su rivista::01m Editorial/Introduzione in rivista
Clinical conundrum. Three management strategies for three-vessel coronary artery disease? / Biondi-Zoccai, Giuseppe; Frati, Giacomo; Miraldi, Fabio; Chiariello, Giovanni A; Versaci, Francesco. - In: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. - ISSN 0160-2446. - 76:5(2020), pp. 489-491. [10.1097/FJC.0000000000000900]
File allegati a questo prodotto
File Dimensione Formato  
Biondi-Zoccai_Clinical-conundrum_2020.pdf

accesso aperto

Note: https://journals.lww.com/cardiovascularpharm/Fulltext/2020/11000/Clinical_Conundrum__Three_Management_Strategies.1.aspx
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 186.06 kB
Formato Adobe PDF
186.06 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1473421
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact